Pentavalent Vaccine Candidate for Meningitis Makes Its Case
(MedPage Today) -- In a randomized trial conducted in the African meningitis belt, an investigational pentavalent meningococcal vaccine proved safe and with noninferior immunogenicity to a licensed quadrivalent product, likely paving the way for...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: African Health | American Health | International Medicine & Public Health | Men | Meningitis | Meningitis Vaccine | Vaccines